General Information
Revision date
2019-10-07
Product name
Carboplatin (Diammine(1,1-cyclobutanedicarboxylato)platinum(II))
Substance name
Carboplatin (Diammine(1,1-cyclobutanedicarboxylato)platinum(II))
CAS No.
41575-94-4
supplier name
Scafell Organics
Emergency telephone
+44 (0) 7590 545705
Icons in SDS
Company Information
company name
Molekula Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
info@molekula.com, kbowen@molekula.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H302+H312+H332, H312, H317, H332, H334, H360
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
CLP CLASSIFICATION
Acute toxicity (oral), Category 4 H302 Acute toxicity (dermal), Category 4 H312 Acute toxicity (inhalation:dust,mist) Category 4 H332 Respiratory sensitisation, Category 1B H334 Skin sensitisation, category 1B H317 Reproductive toxicity, Category 1B H360
Hazard statements
see section 16 : H302+H312+H332 - Harmful if swallowed, in contact with skin or if inhaled. H317 - May cause an allergic skin reaction. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. H360 - May damage fertility or the unborn child.
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling according to Regulation (EC) No. 1272/2008 [CLP]Extra labelling to displayExtra classification(s) to display
Hazard pictograms
GHS07 GHS08
Signal word
Danger
Precautionary statements
P201 - Obtain special instructions before use. P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P263 - Avoid contact during pregnancy and while nursing. P280 - Wear protective gloves/protective clothing/eye protection/face protection. P301+P312 - IF SWALLOWED: Call a POISON CENTRE or doctor if you feel unwell. P308+P313 - IF exposed or concerned: Get medical advice/attention.
2.3 Other hazards
This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII
